Physician profile
Ravi Munver
NPI 1891741906
$529,059.84
in general payments reported to CMS, 2019-2025
21 companies · $137K in 2025
The $137K reported for 2025 was more than what 99% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39K · 2020: $45K · 2021: $4,045 · 2022: $29K · 2023: $78K · 2024: $197K · 2025: $137K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $331K · Travel and Lodging: $36K · Honoraria: $29K · Food and Beverage: $12K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,400 · Education: $2,030.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $330,753.00 |
| Travel and Lodging | $36,040.30 |
| Honoraria | $29,400.00 |
| Food and Beverage | $11,636.14 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,400.00 |
| Education | $2,030.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $357,824.96 | 2021-2025 | Aquabeam System, Aquabeam Robotic System |
| Urogen Pharma, INC. | $67,348.78 | 2022-2025 | Jelmyto |
| Boston Scientific Corporation | $61,098.30 | 2019-2025 | Lithovue, General - Therapies, Stone Cone |
| Amniox Medical, INC. | $22,638.50 | 2019-2020 | |
| Intuitive Surgical, INC. | $9,630.25 | 2019-2025 | |
| Biotissue Holdings INC. | $7,422.05 | 2019-2020 | |
| Calyxo, INC. | $1,339.75 | 2023-2025 | Cvac Aspiration System |
| Edap Technomed INC | $452.14 | 2024-2025 | |
| Profound Medical Corp. | $311.46 | 2022-2025 | Tulsa-Pro |
| Pfizer INC. | $151.29 | 2019-2023 | |
| Olympus America INC. | $141.94 | 2021 | |
| Teleflex LLC | $138.14 | 2023 | Urolift |
| Laborie Medical Technologies Corp. | $119.56 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Ambu INC. | $109.76 | 2020-2024 | |
| Ethicon US, LLC | $104.38 | 2021-2023 | Enseal X1 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Histosonics, INC. | $65.42 | 2025 | |
| Conmed Corporation | $60.01 | 2025 | Airseal |
| Angiodynamics, INC. | $47.14 | 2024 | Nanoknife |
| Kerecis Limited | $22.01 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Immunitybio, INC. | $19.93 | 2025 | |
| Astellas Pharma US INC | $14.07 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ravi Munver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.